Joseph L. Kuti
- Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance 83
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 123
- Pharmacology top 0.05%
- Antibiotics Pharmacokinetics and Efficacy 201
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 44
- Epidemiology top 0.5%
- Pneumonia and Respiratory Infections 86
-
- Antimicrobial Resistance in Staphylococcus 40
-
- Nosocomial Infections in ICU 20
-
- Streptococcal Infections and Treatments 14
- Co-authors
- David P. NicolauCharles H. NightingaleChonghua LiAnthony M. NicasioAryun KimSu Young LeeJared L. CrandonGeorge L. Drusano
- Journals
- SHILAP Revista de lepidopterología (2 papers)Clinical Microbiology Reviews (1 paper)Clinical Infectious Diseases (5 papers)
- Partner nations
- United StatesGermanySaudi Arabia
In The Last Decade
Joseph L. Kuti
255 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Applied Microbiology and Biotechnology 2.0k
- Molecular Medicine 3.4k
- Pharmacology 5.1k
- Clinical Biochemistry 1.1k
- Epidemiology 3.2k
Countries citing papers authored by Joseph L. Kuti
This map shows the geographic impact of Joseph L. Kuti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph L. Kuti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph L. Kuti more than expected).
Fields of papers citing papers by Joseph L. Kuti
This network shows the impact of papers produced by Joseph L. Kuti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph L. Kuti. The network helps show where Joseph L. Kuti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joseph L. Kuti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 31 | |
| 12 | 2023 | 9 | |
| 13 | 2022 | 4 | |
| 14 | 2021 | 2 | |
| 15 | 2018 | 43 | |
| 16 | 2014 | 15 | |
| 17 | 2011 | 4 | |
| 18 | 2010 | 51 | |
| 19 | Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles | 2008 | 2 |
| 20 | 2007 | 8 |
About Joseph L. Kuti
Joseph L. Kuti is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 264 papers that have together received 7.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (201 papers), Antibiotic Resistance in Bacteria (123 papers), Pneumonia and Respiratory Infections (86 papers), Antibiotic Use and Resistance (83 papers), Bacterial Identification and Susceptibility Testing (44 papers), Antimicrobial Resistance in Staphylococcus (40 papers), Nosocomial Infections in ICU (20 papers) and Streptococcal Infections and Treatments (14 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (2.0k citations), Molecular Medicine (3.4k citations) and Pharmacology (5.1k citations). Joseph L. Kuti has collaborated with scholars based in United States, Germany and Saudi Arabia. Frequent co-authors include David P. Nicolau, Charles H. Nightingale, Chonghua Li, Anthony M. Nicasio, Aryun Kim, Su Young Lee, Jared L. Crandon, George L. Drusano, C Andrew DeRyke and Xiaoli Du. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Microbiology Reviews and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.